These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30488669)

  • 21. Isotype-Specific Fc Effector Functions Enhance Antibody-Mediated Rift Valley Fever Virus Protection
    Cartwright HN; Barbeau DJ; McElroy AK
    mSphere; 2021 Oct; 6(5):e0055621. PubMed ID: 34494884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
    J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.
    Soi RK; Rurangirwa FR; McGuire TC; Rwambo PM; DeMartini JC; Crawford TB
    Clin Vaccine Immunol; 2010 Dec; 17(12):1842-9. PubMed ID: 20876822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.
    Papin JF; Verardi PH; Jones LA; Monge-Navarro F; Brault AC; Holbrook MR; Worthy MN; Freiberg AN; Yilma TD
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14926-31. PubMed ID: 21873194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein.
    Hao M; Zhang G; Zhang S; Chen Z; Chi X; Dong Y; Fan P; Liu Y; Chen Y; Song X; Liu S; Yu C; Li J; Xia X
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32120864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
    Heise MT; Whitmore A; Thompson J; Parsons M; Grobbelaar AA; Kemp A; Paweska JT; Madric K; White LJ; Swanepoel R; Burt FJ
    Epidemiol Infect; 2009 Sep; 137(9):1309-18. PubMed ID: 19171081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice.
    Prajeeth CK; Zdora I; Saletti G; Friese J; Gerlach T; Wilken L; Beicht J; Kubinski M; Puff C; Baumgärtner W; Kortekaas J; Wichgers Schreur PJ; Osterhaus ADME; Rimmelzwaan GF
    Emerg Microbes Infect; 2024 Dec; 13(1):2373313. PubMed ID: 38946528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.
    Lorenzo G; Martín-Folgar R; Rodríguez F; Brun A
    Vaccine; 2008 Sep; 26(41):5255-62. PubMed ID: 18682268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cytokines following vaccination of goats with a recombinant capripoxvirus vaccine expressing Rift Valley fever virus proteins.
    Ayari-Fakhfakh E; Ghram A; Albina E; Cêtre-Sossah C
    Vet Immunol Immunopathol; 2018 Mar; 197():15-20. PubMed ID: 29475501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
    Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
    Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modifying the NSs gene to improve live-attenuated vaccine for Rift Valley fever.
    Lihoradova O; Ikegami T
    Expert Rev Vaccines; 2012 Nov; 11(11):1283-5. PubMed ID: 23249225
    [No Abstract]   [Full Text] [Related]  

  • 32. Virus-like particle-based countermeasures against Rift Valley fever virus.
    Koukuntla R; Mandell RB; Flick R
    Zoonoses Public Health; 2012 Sep; 59 Suppl 2():142-50. PubMed ID: 22958258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
    Ikegami T
    Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity.
    Holman DH; Penn-Nicholson A; Wang D; Woraratanadharm J; Harr MK; Luo M; Maher EM; Holbrook MR; Dong JY
    Clin Vaccine Immunol; 2009 Nov; 16(11):1624-32. PubMed ID: 19776190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of a Candidate Live Attenuated Vaccine for Rift Valley Fever Virus with a Two-Segmented Genome.
    Ayers VB; Huang YS; Dunlop JI; Kohl A; Brennan B; Higgs S; Vanlandingham DL
    Viral Immunol; 2023 Jan; 36(1):33-40. PubMed ID: 36399689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe.
    Mansfield KL; Banyard AC; McElhinney L; Johnson N; Horton DL; Hernández-Triana LM; Fooks AR
    Vaccine; 2015 Oct; 33(42):5520-5531. PubMed ID: 26296499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
    Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
    Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel approaches to develop Rift Valley fever vaccines.
    Indran SV; Ikegami T
    Front Cell Infect Microbiol; 2012; 2():131. PubMed ID: 23112960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice.
    Terasaki K; Juelich TL; Smith JK; Kalveram B; Perez DD; Freiberg AN; Makino S
    Sci Rep; 2018 Nov; 8(1):17097. PubMed ID: 30459418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rift valley fever vaccines.
    Ikegami T; Makino S
    Vaccine; 2009 Nov; 27 Suppl 4():D69-72. PubMed ID: 19837291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.